References
- Javitt N B, Shiu M H, Former J G. Bile salt synthesis in the transplanted human liver. Gastroenterology 1971; 60: 405–8
- Shiftman M L, Carithers R L, Jr, Posner M, Moore E W. Recovery of bile secretion following orthotopic liver transplantation. J Hepatol 1991; 12: 351–61
- Ericzon B-G, Eusufzai S, Kubota K, Einarsson K, Angelin B. Biliary lipid secretion earlv after liver transplantation. Transplantation Proc 1990; 22: 1537-S
- Friman S, Person H, Karlberg I, Svanvik J. The bile acid independent How is reduced in the transplanted liver. Transplant hit 1992; 5: 163–7
- Leuschner U, Fischer H, Kurtz W, Gulduna S, Hubner K, Hellstern A, et al. Ursodeoxycholic acid in primary biliary cirrhosis. Results of a controlled double-blind trial. Gastroenterology 1990; 97: 1268–74
- Poupon R E, Balbou B, Eschwege E, Poupon R. A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. New Enal J Med 1991; 324: 548–54
- Ullrich D, Rating D, Schröter W, Hanefeld F, Bircher J. Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 1987; 2: 1324
- Podda M, Ghezzi C, Battezzati P M, Bertolini E, Crosignani A, Petroni M L, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 1989; 34: S59–65
- O'Brien C, Senior J R, Batta Renu-Aurora AK, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 36-month open pilot trial. Hepatology 1991; 14: 838–47
- Starzl T E, Koep L J, Halgrimson C G, Hord J, Schroter G P, Porter K A, et al. Fifteen years of clinical liver transplantation. Gastroenterology 1979; 77: 375–88
- Kirby R M, McMaster P, Clements D, Hubscher S G, Angrisami L, Sealey M, et al. Orthotopic liver transplantation: postoperative complications and their management. Br J Surg 1987; 74: 3–11
- Cuervas-Mons V, Martinez A J, Dekker A, Starzl T E, van Thiel O H. Adult liver transplantation: an analysis of the early courses of death in 40 consecutive cases. Hepatology 1986; 6: 495–501
- Friman S, Persson H, Schersten T, Svanvik J, Karlberg I. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation. Transplant Int 1992; 5: 187–9
- Olausson M, Mjörnstedt L, Wramner L, Persson H, Karlberg I, Friman S. Adjuvant treatment with ursodeoxycholic acid prevents acute rejection in rats receiving heart allografts. Transplant Int 1992; 5: 539–41
- Olausson M, Mjörnstedt L, Lindholm L, Brynger H. Non-suture organ grafting to the neck vessels in rats. Acta Chir Scand 1984; 150: 463–7
- Mjörnstedt L, Olausson M, Hedman L, Lindholm L, Brynger H. Induction of long-term heart allograft survival in the rat by rabbit ATG. Int Arch Allergy Appl Immunol 1984; 74: 193–9
- Ichida F. Clinical experience with ursodeoxycholic acid for chronic hepatitis. Diagn Treat 1961; 36: 388
- Nakagawa S, Makino I, Ishizaki T, Dohi I. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 1977; 2: 367–9
- Heuman D M, Komito S F, Pandak W M, Hylemon P B, Vlahcevic Z R. Tauroursodeoxycholic acid protects against cholestatic and hepatocytolvtic toxicity of more hydrophobic bile salts. Gastroenterology 1989; 96: A607
- Galle P R, Theilmann L, Raedsch R, Otto G, Stiehl A. Urso-deoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990; 12: 486–91
- Dumont M, Uchman S, Erlinger S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980; 79: 82–9
- Scherstén T, Linblad L. Biliary cholesterol output during ursodeoxycholic acid secretion in man. Biological effects of bile acids, G Paumgartner, A Stiehl, W Gerok. MTP Press, LancasterUK 1979
- Korneau B, Tint G S, Wilson D J, Leevy C B, Salen G. Randomized prospective trial of ursodeoxycholic acid (UDCA) in liver transplant recipients. Hepatology 1993; 336A
- Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of Class I and Class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12–15
- Leuschner U, Dieues H P, Guldiituna S, Birkenfeld G, Leuschner M. Ursodeoxycholic acid (UDCA) influences immune parameters in patients with primary biliary cirrhosis (PBC). Hepatology 1990; 12: 957
- Lacaille F, Paradis K. The immunosuppressive effect of ursodeoxycholic acid. A comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993; 18: 165–72